NexImmune, Inc. announced that, in order to reduce its cash expenditures while continuing to pursue its existing strategic plan, its Board of Directors approved and its management is implementing an approximately 53% reduction in workforce, designed to reduce costs and extend the Company?s cash. The realignment will reduce the Company?s workforce from 47 to 22 full-time employees as of September 5, 2023.